Please provide your email address to receive an email when new articles are posted on . The FDA approved an expanded indication for ruxolitinib cream to include children aged 2 to 11 years with atopic ...

Regular nonsteroidal anti-inflammatory use linked to erectile dysfunction. Mar. 7, 2011— -- The regular use of nonsteroidal anti-inflammatory drugs (NSAIDs) is associated with higher odds of ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Approximately 1.8 million children aged 2 to 5 years are ...

In the trial, 62.5% of Opzelura participants achieved a four-point improvement in itch by week eight versus 19.8% on vehicle.